Document is current
Any future updates will be listed below
-
Authors
Delgado, Jose F.
Owen, Joshua W.
Pritchard, William F.
Varble, Nicole A.
Lopez-Silva, Tania L.
Mikhail, Andrew S.
Arrichiello, Antonio
Ray, Trisha
Morhard, Robert
Borde, Tabea
Saccenti, Laetitia
Xu, Sheng
Rivera, Jocelyne
Schneider, Joel P.
Karanian, John W.
Wood, Bradford J.
-
Funding
Funding for this research was provided by:
National Institutes of Health (Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242, Z01 1ZID BC011242)
National Cancer Institute (1ZIABC011313-09, 1ZIABC011313-09)
National Institutes of Health Clinical Center
- License Information
-
More Information
Article History
Received: 9 June 2024
Accepted: 22 August 2024
First Online: 3 September 2024
Competing interests
: Philips and NIH have a patent licensing agreement under which NIH receives royalties, a portion of which are then shared with B.J.W. B.J.W is Principal Investigator on the following CRADA’s = Cooperative Research & Development Agreements, between NIH and industry: Philips (CRADA), Celsion Corp (now Imunon) (CRADA), BTG Biocompatibles (now Boston Scientific) (CRADA), Siemens Healthineers (CRADA), Varian Interventional Systems (CRADA), NVIDIA (CRADA), XAct Robotics (CRADA), ProMaxo (CRADA), Uro-1 (CRADA), EndoWave (CRADA), MediView (CRADA). N.V. is a senior scientist at Philips. J.F.D., J.W.O., W.F.P., T.L.L-S, A.S.M., A.A., T.R., R.M., T.B., L.S., S.X., J.R., J.S., and J.W.K do not declare conflict of interests.
